FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.01.2020
End date : 31.12.2020
We demonstrate that dynamic changes in the levels of O-GlcNAcylation are critically required for osteoclastogenesis. Inhibition of this dynamic regulation prevents osteoclast differentiation and ameliorates local and systemic bone loss in experimental arthritis. We now aim to further characterize the signaling pathways regulated by O-GlcNAcylation in inflammatory and non-inflammatory bone loss and to validate targeted modulation of O-GlcNAcylation as a therapeutic option for aberrant bone loss.